Literature DB >> 11069033

Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma.

J Kalla1, S Stilgenbauer, C Schaffner, S Wolf, G Ott, A Greiner, A Rosenwald, H Döhner, H K Müller-Hermelink, P Lichter.   

Abstract

The translocation t(11;18)(q21;q21), which is the most frequent chromosomal aberration in extranodal marginal zone B cell lymphomas of MALT-type, was characterised in a series of 34 biopsies, including 18 gastric non-Hodgkin's lymphomas (NHL) of MALT-type, six MALT-type NHL of extragastral origin and 10 extranodal large B cell lymphomas (LBL). Based on fluorescence in situ hybridisation, STS-PCR analysis and screening of genomic PAC libraries, a physical map of contiguous DNA probes on chromosome 11 was constructed containing the anti-apoptotic genes API2 and API1 adjacent to the translocation breakpoint. RACE-PCR experiments revealed MALT1 the chromosome 18-derived fusion partner of API2, which has also been reported recently by other groups. RT-PCR analysis and DNA sequencing demonstrated the expression of an API2-MALT1 fusion transcript in 18/24 gastral and extragastral MALT-type lymphomas. In none of 10 LBLs was a translocation specific RT-PCR product detected. Five variants of the fusion transcript were identified and in all instances the open reading frame of the fused portion of the MALT1 gene was maintained. The molecular analysis of these variants allowed the design of optimised assays for the diagnosis of the API2-MALT1 gene rearrangement.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069033     DOI: 10.1038/sj.leu.2401918

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

Review 1.  Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.

Authors:  M-Q Du; J C Atherton
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

2.  Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.

Authors:  Frédéric Charlotte; Kamal Doghmi; Nathalie Cassoux; Hongtao Ye; Ming-Qing Du; Michèle Kujas; Annette Lesot; George Mansour; Phuc Lehoang; Nicole Vignot; Frédérique Capron; Véronique Leblond
Journal:  Virchows Arch       Date:  2005-12-02       Impact factor: 4.064

Review 3.  Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development.

Authors:  Xavier Sagaert; Eric Van Cutsem; Gert De Hertogh; Karel Geboes; Thomas Tousseyn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-04       Impact factor: 46.802

4.  Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways.

Authors:  Ellen D Remstein; Paul J Kurtin; C David James; Xiao-Yang Wang; Reid G Meyer; Gordon W Dewald
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 5.  Chromosomal translocation t(11;18)(q21;q21) in gastrointestinal mucosa associated lymphoid tissue lymphoma.

Authors:  S Nakamura; T Matsumoto; S Nakamura; Y Jo; K Fujisawa; H Suekane; T Yao; M Tsuneyoshi; M Iida
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

6.  Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas.

Authors:  J Krugmann; A Tzankov; S Dirnhofer; F Fend; R Greil; R Siebert; M Erdel
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

7.  Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.

Authors:  Heidi Noels; Riet Somers; Hongxiang Liu; Hongtao Ye; Ming-Qing Du; Christiane De Wolf-Peeters; Peter Marynen; Mathijs Baens
Journal:  PLoS One       Date:  2009-03-12       Impact factor: 3.240

8.  Clinicopathologic comparison between the API2-MALT1 chimeric transcript-positive and -negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type.

Authors:  Tsuneya Nakamura; Shigeo Nakamura; Takio Yokoi; Hiroko Suzuki; Kazuhiko Ohashi; Masao Seto
Journal:  Jpn J Cancer Res       Date:  2002-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.